A Quality-Adjusted Time Without Symptoms or Toxicity (Q-Twist) Analysis of Patients in CheckMate 649: Nivolumab Plus Chemotherapy Versus Chemotherapy As First-Line Treatment for Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC).
Journal of Clinical Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined